Screening With PSA Test Has Small Impact On Prostate Cancer Deaths But Leads To Overdiagnosis

The largest study to date investigating a single invitation to a PSA blood test* to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of some aggressive cancers. 

The CAP trial, published in the Journal of the American Medical Association...